CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -45.61%132.76M | 110.33%242.21M | -44.96%89.03M | -42.23%103.07M | 44.15%244.08M | -45.76%115.15M | 16.71%161.76M | 4.58%178.4M | -66.28%169.32M | 477.74%212.31M |
Transactional financial assets | 127.00%273.7M | -51.04%114.47M | 21.75%250.64M | 6.49%240.67M | -57.27%120.58M | -1.97%233.81M | -29.41%205.87M | -17.28%226.01M | 5,660.46%282.15M | 1,494.16%238.52M |
Notes receivable and accounts receivable | -12.45%164.06M | -15.69%189.47M | -20.78%198.48M | -21.41%192.75M | -16.56%187.39M | -1.63%224.73M | -0.29%250.54M | -3.28%245.25M | -9.87%224.58M | -17.72%228.46M |
-Notes receivable | -26.62%47.79M | -30.42%71.66M | -19.97%73.72M | -18.41%64.33M | -12.14%65.13M | 20.13%102.99M | 3.69%92.11M | -3.73%78.85M | -23.69%74.13M | -24.87%85.74M |
-Accounts receivable | -4.90%116.27M | -3.22%117.81M | -21.25%124.76M | -22.83%128.42M | -18.74%122.26M | -14.70%121.73M | -2.47%158.43M | -3.07%166.4M | -1.04%150.45M | -12.73%142.72M |
Other receivables (including interest and dividends) | -24.10%3.23M | 5.55%3.64M | 604.57%14.24M | 785.38%14.2M | -23.63%4.25M | 324.99%3.44M | 324.37%2.02M | 250.90%1.6M | 2,429.40%5.57M | 78.97%810.36K |
-Other receivable | ---- | ---- | ---- | 785.38%14.2M | ---- | 324.99%3.44M | ---- | 250.90%1.6M | ---- | 78.97%810.36K |
Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Advance payment | 624.86%8.71M | -9.72%5.23M | 12.17%8.9M | 40.54%5.82M | -82.10%1.2M | 69.17%5.79M | 40.95%7.94M | -57.82%4.14M | -54.63%6.71M | -63.88%3.42M |
Inventories | -7.89%120.23M | -0.71%113.79M | -5.77%119.34M | -7.20%124.5M | -16.14%130.53M | -19.58%114.6M | -11.55%126.64M | -16.88%134.16M | 6.48%155.64M | 13.74%142.5M |
Receivable financing | 19.81%16.49M | -18.76%18.47M | -33.90%16.13M | -34.30%10.02M | -6.47%13.76M | 104.04%22.74M | 37.68%24.41M | 25.53%15.25M | -5.19%14.71M | -9.84%11.15M |
Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Non-current assets due within one year | ---- | --36.35M | --36.01M | --35.68M | --35.35M | ---- | ---- | ---- | --0 | ---- |
Other current assets | -9.91%2.57M | 61.07%2.51M | 30.63%852.77K | 1,509.15%2.35M | 1,496.38%2.86M | -33.06%1.56M | --652.83K | --146K | -72.46%179K | -58.92%2.32M |
Total current assets | -2.47%721.74M | 0.60%726.13M | -5.92%733.63M | -9.43%729.06M | -13.84%739.99M | -14.02%721.83M | -8.10%779.83M | -8.65%804.97M | -8.00%858.87M | 73.95%839.49M |
Non Current assets | ||||||||||
Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other equity investment | ---- | ---- | --7.23M | --7.08M | --7.09M | --7.26M | ---- | ---- | --0 | ---- |
Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | --35.01M | ---- | ---- | --0 | ---- |
Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long-term equity investment | --7.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Fixed assets | ---- | ---- | ---- | 22.42%236.23M | ---- | 20.10%236.06M | ---- | 16.91%192.97M | ---- | 102.25%196.55M |
Constru in process | ---- | ---- | ---- | -36.11%7.51M | ---- | -52.91%1.43M | ---- | -35.10%11.76M | ---- | -94.60%3.03M |
Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Intangible assets | -1.14%33.11M | 0.90%33.64M | 16.58%34.54M | 13.06%33.92M | 89.11%33.49M | 86.19%33.35M | 70.98%29.63M | 71.70%30.01M | 5.26%17.71M | 5.29%17.91M |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long deferred expense | -29.03%2.51M | -1.34%2.8M | 24.91%3.1M | 35.25%3.26M | 37.77%3.53M | 116.84%2.84M | 153.41%2.48M | 171.36%2.41M | 168.92%2.56M | 28.47%1.31M |
Deferred tax assets | 127.34%2.69M | 103.81%2.63M | -12.35%1.22M | -30.06%1.29M | 12.71%1.18M | 32.88%1.29M | -55.40%1.39M | -39.01%1.84M | -63.85%1.05M | -67.96%971.35K |
Usufruct assets | 16.95%2.14M | 25.18%2.37M | 86.93%2.61M | 98.06%2.84M | 25.99%1.83M | 28.03%1.89M | 1.18%1.4M | 2.09%1.44M | 0.83%1.45M | 1.20%1.48M |
Other non current assets | 410.78%8.21M | 134.18%12.05M | -84.68%2.19M | -76.15%3.19M | -87.02%1.61M | -55.33%5.14M | 459.87%14.32M | 388.15%13.38M | 872.32%12.39M | 711.92%11.51M |
Total non current assets | 3.85%298.22M | -8.41%296.98M | 9.93%293.55M | 16.36%295.33M | 22.50%287.17M | 39.32%324.26M | 19.50%267.03M | 21.61%253.8M | 26.32%234.43M | 31.36%232.75M |
Total assets | -0.70%1.02B | -2.20%1.02B | -1.88%1.03B | -3.25%1.02B | -6.05%1.03B | -2.44%1.05B | -2.34%1.05B | -2.86%1.06B | -2.30%1.09B | 62.52%1.07B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | -34.34%786.8K | 641.59%3.02M | --613.62K | --607.64K |
Notes payable and accounts payable | 1.11%70.52M | -26.26%62.93M | -12.37%75.2M | -17.80%84.1M | -38.27%69.74M | -14.07%85.34M | -26.05%85.82M | -34.26%102.31M | -23.62%112.99M | -28.05%99.31M |
-Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | -94.99%850K | -38.05%6.95M | -63.95%6.1M | -52.68%11.2M |
-Accounts payable | 1.11%70.52M | -26.26%62.93M | -11.50%75.2M | -11.81%84.1M | -34.75%69.74M | -3.15%85.34M | -14.23%84.97M | -33.96%95.36M | -18.41%106.89M | -22.96%88.11M |
Contract liabilities | -41.04%2.3M | -22.58%2.83M | -11.66%3.63M | 36.72%3.28M | 6.01%3.9M | -15.23%3.65M | -38.48%4.11M | -72.06%2.4M | -55.31%3.68M | -36.61%4.31M |
Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Salaries payable | 15.83%8.43M | 12.08%11.23M | 0.98%8.78M | 2.12%7.64M | 1.69%7.28M | -13.66%10.02M | 0.11%8.7M | -19.39%7.48M | 21.92%7.16M | 12.51%11.6M |
Taxs payable | 101.50%1.33M | -24.08%2.62M | -52.29%1.64M | -84.83%859.47K | -70.03%659.25K | 297.67%3.45M | 2.45%3.44M | 367.81%5.67M | 56.73%2.2M | -46.54%867.78K |
Other payable (including interest and dividends) | 249.63%247.03K | 6.17%253.27K | -27.64%167.64K | -89.29%134.76K | -93.31%70.66K | -71.09%238.56K | -53.88%231.69K | 85.10%1.26M | 853.64%1.06M | 152.64%825.27K |
-Other payable | ---- | ---- | ---- | -89.29%134.76K | ---- | -71.09%238.56K | ---- | 85.10%1.26M | ---- | 152.64%825.27K |
Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Non current liabilities due within one year | 296.83%802.09K | 405.91%1.01M | 992.35%1M | 978.78%993.26K | 125.74%202.12K | 127.29%200.51K | 34.96%91.98K | 37.21%92.07K | 35.84%89.54K | 35.22%88.22K |
Other current liabilities | -54.25%14.52M | -19.75%28.22M | -7.26%34.75M | -17.01%33.77M | -26.88%31.74M | -27.03%35.17M | -11.41%37.47M | -2.56%40.69M | -21.61%43.4M | -12.34%48.19M |
Total current liabilities | -13.60%98.14M | -20.98%109.09M | -11.00%125.17M | -19.73%130.78M | -33.64%113.59M | -16.73%138.07M | -21.35%140.64M | -23.97%162.92M | -21.82%171.18M | -21.84%165.8M |
Current liabilities | ||||||||||
Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Perpetual Debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Deferred tax liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Long term deferred income | 458.12%10.85M | 424.75%11.14M | 74.17%1.6M | 67.59%1.78M | 62.08%1.94M | 58.55%2.12M | -37.77%920.26K | -34.51%1.06M | -31.77%1.2M | -29.43%1.34M |
Lease liabilities | -13.60%1.39M | -16.92%1.38M | 27.25%1.72M | 41.61%1.92M | 19.76%1.61M | 25.11%1.66M | 0.88%1.35M | 1.98%1.35M | 1.78%1.35M | 1.47%1.33M |
Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Total non current liabilities | 244.21%12.25M | 230.76%12.52M | 46.27%3.32M | 53.02%3.69M | 39.69%3.56M | 41.89%3.79M | -29.31%2.27M | -26.41%2.41M | -27.58%2.55M | -26.93%2.67M |
Total liabilities | -5.77%110.39M | -14.26%121.62M | -10.09%128.49M | -18.67%134.47M | -32.57%117.15M | -15.80%141.85M | -21.49%142.91M | -24.01%165.33M | -21.91%173.73M | -21.93%168.47M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%108.8M | 0.00%108.8M | 0.00%108.8M | 0.00%108.8M | 60.00%108.8M | 60.00%108.8M | 60.00%108.8M | 60.00%108.8M | 0.00%68M | 33.33%68M |
Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
-Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Capital reserve funds | 0.00%534.51M | 0.00%534.51M | 0.00%534.51M | 0.00%534.51M | -7.09%534.51M | -7.09%534.51M | -7.09%534.51M | -7.09%534.51M | 0.00%575.31M | 272.04%575.31M |
Surplus reserve funds | 7.81%38.88M | 7.81%38.88M | 12.85%36.07M | 12.85%36.07M | 12.85%36.07M | 12.85%36.07M | 25.33%31.96M | 25.33%31.96M | 25.33%31.96M | 25.33%31.96M |
Retained profit | -1.60%225.54M | 0.66%224.32M | -3.88%218.18M | -3.31%209.22M | -5.46%229.21M | -1.71%222.86M | 3.36%226.98M | 7.14%216.38M | 7.17%242.45M | 7.31%226.74M |
Less:Treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Other composite income | 59.07%422.68K | -1,188.18%-5.94M | 114.04%454.47K | -16.06%251.22K | 38.96%265.73K | 224.87%546.26K | 171.61%212.33K | 175.03%299.27K | 71.92%191.22K | 34.76%168.15K |
Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Specific reserves | -22.08%907.78K | -36.90%919.99K | -62.61%560.41K | -28.11%1.07M | -29.52%1.17M | -9.30%1.46M | 2.14%1.5M | 1.36%1.49M | 14.96%1.65M | 11.79%1.61M |
Shareholders equity without minority interests | -0.10%909.06M | -0.30%901.49M | -0.60%898.57M | -0.39%889.92M | -1.04%910.01M | 0.05%904.24M | 1.57%903.96M | 2.42%893.44M | 2.56%919.56M | 103.56%903.78M |
Minority interests | --504.94K | --8.72K | --119.16K | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Total shareholder equity | -0.05%909.57M | -0.30%901.5M | -0.58%898.69M | -0.39%889.92M | -1.04%910.01M | 0.05%904.24M | 1.57%903.96M | 2.42%893.44M | 2.56%919.56M | 103.56%903.78M |
Total liabilityies and equity | -0.70%1.02B | -2.20%1.02B | -1.88%1.03B | -3.25%1.02B | -6.05%1.03B | -2.44%1.05B | -2.34%1.05B | -2.86%1.06B | -2.30%1.09B | 62.52%1.07B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.